Elicera Therapeutics AB's total assets for Q1 2025 were kr46.38M, an increase of 68.27% from the previous quarter. DE:8E8 total liabilities were kr13.63M for the fiscal quarter, a 100.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.